Financial Review FULL YEAR 2018

Financial Review FULL YEAR 2018 CLARIANT INTERNATIONAL LTD Rothausstrasse 61 4132 Muttenz Switzerland

Page 1 of 16 Key Financial Group Figures CHF m 2018 % of sales CHF m 2017 % of sales Sales 6623 100.0 6 377 100.0 Local currency growth (LC): 5% Organic growth 1 5% Acquisitions/divestitures 0% Currencies 1% Gross profit 1933 29.2 1902 29.8 EBITDA before exceptional items* 1 018 15.4 974 15.3 EBITDA* 871 13.2 813 12.7 Operating income before exceptional items* 693 10.5 673 10.6 Operating income 546 8.2 496 7.8 Net income 356 5.4 302 4.7 Basic earnings per share (CHF/share) 1.02 0.84 Adjusted earnings per share (CHF/share)* 1.50 1.47 Operating cash flow 530 428 Other key figures total Group: 31.12.2018 31.12.2017 Net debt 1 374 1539 Equity (including non-controlling interests) 2970 2939 Gearing 46% 52% Return on invested capital (ROIC)** 10.1% 10.2% Number of employees 17 901 18 135 1 Throughout this statement the term organic growth is used to mean volume and price effects excluding the impacts of changes in FX rates and acquisitions/divestitures. * See Definition of Terms of Financial Measurements on pages 4 and 5. ** Clariant calculates ROIC by dividing NOPLAT before exceptional items by the average net capital employed. NOPLAT is calculated by taking the operating income before exceptional items adjusted by the expected tax rate. Net capital employed also considers operating cash and capitalized operating leases.

Page 2 of 16 FINANCIAL DISCUSSION FULL YEAR Sales and Net Results 2018* Sales increased by 5 % organically in local currency. In Swiss francs, sales increased by 4 % compared to the previous year. The gross margin for the full year 2018 was 29.2 % of sales compared to 29.8 % recorded in the prior-year period due to a less favorable product mix. Selling, general and administrative costs decreased in 2018 to 19.8 % of sales compared to 20.3 % in 2017. Research and development costs remained at CHF 209 million in the full year of 2018 at a comparable level to the previous year at CHF 211 million. Income from associates and joint ventures of CHF 130 million in the full year of 2018 was above the level of the previous year (CHF 103 million), mainly driven by the income from the participation in Stahl. The net financial result decreased to CHF -81 million in 2018 in comparison to CHF -59 million in 2017. Excluding the currency result, the financial result was CHF -81 million for the full year of 2018 compared to CHF -65 million in 2017. While the financial expenses remained unchanged, the decrease was caused by the reduction of financial income to CHF 19 million in 2018 from CHF 35 million in 2017. Tax expense of CHF 109 million was recorded in 2018 compared to CHF 135 million tax expense recorded in the prior year. In 2018, there was no material adjustment of deferred tax assets due to US tax reform as in the prior year, leading to an improved effective tax rate. The recorded tax expense was adversely impacted by one-time events and the non-recognition of deferred tax assets on tax losses incurred by subsidiaries mainly in USA, China and Canada as their recoverability was not considered probable. Net income amounted to CHF 356 million in the full year of 2018, which was above the CHF 302 million net income reported in the same period of 2017. * The fully consolidated Süd-Chemie India Pvt Ltd. (SCIL) joint venture is included as of 1 April 2017.

Page 3 of 16 Balance Sheet Key Figures December 2018 Cash Flow Total assets decreased to CHF 7.981 billion as of 31 December 2018 from CHF 8.229 billion at the end of 2017 mainly due to the decrease in non-current assets driven by lower PPE and intangible assets. This decrease is a result of disposals and currency differences. Investments in associates and joint ventures decreased to CHF 368 million from CHF 508 million at the end 2017. This is the net effect of the dividends paid mainly by Infraserv companies in Germany, the reduction of the stake in Stahl from 19.7 % to 14.8 % and the subsequent reclassification of the remaining stake to financial assets. Short-term deposits decreased to CHF 26 million from CHF 47 million at the end of 2017. This figure includes short-term deposits with an original maturity between 90 and 365 days. Current financial debts decreased to CHF 529 million from CHF 567 million at the end of December 2017. Equity increased to CHF 2.970 billion from CHF 2.939 billion at the end of 2017. This was mainly due to the net profit for the period amounting to CHF 356 million, to treasury share transactions amounting to CHF 9 million, to the net investment hedges amounting to CHF 28 million and to the effect of fair value adjustment on financial assets amounting to CHF 2 million. The positive effects on equity as of end of December 2018 were partially offset by a distribution from capital contribution reserves of CHF 165 million, by the negative currency translation effect of CHF 146 million, by dividends paid to non-controlling interests amounting to CHF 16 million and by the combined effect of actuarial gains on retirement benefit obligations and a negative return on pension plan assets amounting to a negative CHF 22 million, net of deferred tax. Cash flow from operating activities before changes in working capital and provisions was a positive CHF 802 million for the full year of 2018 compared to a positive CHF 759 million for the full year of 2017. Working capital (including changes in provisions and changes in other current assets and liabilities) increased by CHF 55 million compared with an increase of CHF 230 million for the full year of 2017. Income taxes paid also include the settlement of a tax audit in the amount of CHF 83 million. This payment was fully provided for and had no impact on the income statement. Net cash generated from operating activities was a positive CHF 530 million for the full year of 2018 compared to a positive CHF 428 million for the full year of 2017. Investments in PPE and investments in intangible assets were CHF 237 million and CHF 20 million, respectively, for the full year of 2018, compared to CHF 248 million and CHF 31 million, respectively, for the full year of 2017. Financing activities mainly include the distribution to the shareholders of Clariant and to non-controlling interests, proceeds from and repayments of financial debt, and the related interest paid and received. Net debt decreased to CHF 1.374 billion from CHF 1.539 billion at the end of December 2017. This figure includes current and non-current financial debts, cash and cash equivalents, shortterm deposits and financial instruments with positive fair values reported under other current assets. Gearing, which reflects net financial debt in relation to equity, including non-controlling interests, decreased to 46 % from 52 % at the end of 2017, as a result of the decrease in net debt.

Page 4 of 16 DEFINITION OF TERMS OF FINANCIAL MEASUREMENTS (UNAUDITED) The following financial measurements are supplementary financial indicators. They should be considered in addition to, not as a substitute for, operating income, net income, operating cash flow and other measures of financial performance and liquidity reported in accordance with International Financial Reporting Standards (IFRS). EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) is calculated as operating income plus depreciation of PPE, plus impairment and amortization of intangible assets, and can be reconciled from the Condensed Financial Statements as follows: EBITDA CHF m 2 018 2 017 Operating income 546 496 + Depreciation of PPE 245 231 + Impairment 16 + Amortization of intangible assets 80 70 EBITDA 871 813 EBITDA before exceptional items is calculated as EBITDA plus expenses for restructuring, impairment and transaction-related costs less impairment and gain/loss on disposals. EBITDA before exceptional items CHF m 2 018 2 017 EBITDA 871 813 + Restructuring, impairment and transaction-related costs* 93 180 Impairment (reported under Restructuring, impairment and transaction-related costs) 16 + Loss/gain from the disposal of activities not qualifying as discontinued operations** 54 3 EBITDA before exceptional items 1 018 974 Operating income before exceptional items is calculated as operating income plus restructuring, impairment and transaction-related costs and gain/loss on disposals. Operating income before exceptional items CHF m 2 018 2 017 Operating income 546 496 + Restructuring, impairment and transaction-related costs* 93 180 + Loss/gain from the disposal of activities not qualifying as discontinued operations** 54 3 Operating income before exceptional items 693 673 * Restructuring, impairment and transaction-related costs 2018: CHF 93 million (2017: CHF 180 million), of which: Cost of goods sold CHF 11 million (2017: CHF 10 million); Selling, general and administrative costs CHF 81 million (2017: CHF 158 million); Research and development expenses CHF 1 million (2017: CHF 8 million). Income from associates and joint ventures CHF 0 million (2017: CHF 4 million an expense). ** Loss/gain from the disposal of activities not qualifying as discontinued operations 2018: CHF 54 million loss (2017: CHF 3 million gain) reported under Selling, general and administrative costs, not including income from associates and joint ventures.

Page 5 of 16 Adjusted earnings per share is the earnings per share adjusted for the impact of exceptional items, assuming an adjusted income tax rate of 26% for the period. Adjusted earnings per share CHF m 2 018 2 017 Operating income before exceptional items 693 673 + Amortization of intangible assets 80 70 + Finance income 19 35 Finance costs 100 94 Adjusted income before taxes 692 684 Adjusted income taxes 180 178 Adjusted net income 512 506 Thereof attributable to non-controlling interests 19 25 Thereof attributable to shareholders of Clariant Ltd 493 481 Weighted average number of shares outstanding 329 613 975 328 310 895 Adjusted earnings per share attributable to shareholders of Clariant Ltd (CHF/share) 1.50 1.47 Net debt is the sum of current and non-current financial debt less cash and cash equivalents, short-term deposits and financial derivatives with positive fair values. Net debt CHF m 31.12.2018 31.12.2017 Non-current financial debt 1 711 1727 + Current financial debt 529 567 Cash and cash equivalents 833 701 Short-term deposits 26 47 Financial derivatives with positive fair values 7 7 Net debt 1 374 1539

Page 6 of 16 CONDENSED FINANCIAL STATEMENTS OF THE CLARIANT GROUP Consolidated balance sheets ASSETS 31.12.2018 31.12.2017 CHF m % CHF m % Non-current assets Property, plant and equipment 2 081 2250 Intangible assets 1682 1 775 Investments in associates and joint ventures 368 508 Financial assets 211 50 Prepaid pension assets 30 67 Deferred income tax assets 269 267 Total non-current assets 4 641 58.1 4 917 59.7 Current assets Inventories 1 018 952 Trade receivables 1 017 1 146 Other current assets 366 388 Current income tax receivables 65 56 Short-term deposits 26 47 Cash and cash equivalents 833 701 Total current assets 3325 41.7 3290 40.0 Assets held for sale 15 0.2 22 0.3 Total assets 7 981 100.0 8 229 100.0 EQUITY AND LIABILITIES 31.12.2018 31.12.2017 CHF m % CHF m % Equity Share capital 1228 1228 Treasury shares (par value) 8 10 Other reserves 189 83 Retained earnings 1 767 1459 Total capital and reserves attributable to Clariant shareholders 2 798 2 760 Non-controlling interests 172 179 Total equity 2970 37.2 2939 35.7 Liabilities Non-current liabilities Financial debts 1 711 1727 Deferred income tax liabilities 47 65 Retirement benefit obligations 778 849 Provision for non-current liabilities 125 166 Other liabilities 72 79 Total non-current liabilities 2733 34.2 2886 35.1 Current liabilities Trade and other payables 1266 1 216 Financial debts 529 567 Current income tax liabilities 212 301 Provision for current liabilities 271 320 Total current liabilities 2 278 28.6 2 404 29.2 Total liabilities 5 011 62.8 5290 64.3 Total equity and liabilities 7 981 100.0 8229 100.0

Page 7 of 16 Consolidated income statements CHF m 2 018 % CHF m 2 017 % Sales 6623 100.0 6 377 100.0 Costs of goods sold 4690 70.8 4475 70.2 Gross profit 1 933 29.2 1 902 29.8 Selling, general and administrative costs 1308 19.8 1298 20.3 Research and development 209 3.2 211 3.3 Income from associates and joint ventures 130 2.0 103 1.6 Operating income 546 8.2 496 7.8 Finance income 19 0.3 35 0.5 Finance costs 100 1.5 94 1.5 Income before taxes 465 7.0 437 6.8 Taxes 109 1.6 135 2.1 Net income 356 5.4 302 4.7 Attributable to: Shareholders of Clariant Ltd 337 277 Non-controlling interests 19 25 Basic earnings per share attributable to the shareholders of Clariant Ltd (CHF/share): Diluted earnings per share attributable to the shareholders of Clariant Ltd (CHF/share): 1.02 0.84 1.02 0.84

Page 8 of 16 Consolidated statements of comprehensive income CHF m 2 018 2 017 Net income 356 302 Other comprehensive income: Remeasurements: Actuarial gain/loss on retirement benefit obligations 126 7 Return on retirement benefit plan assets, excluding amount included in interest expense 149 111 Fair value adjustment on financial assets 2 Total items that will not be reclassified subsequently to the income statement, gross 21 118 Deferred tax on remeasurements 1 36 Total items that will not be reclassified subsequently to the income statement, net 20 82 Net investment hedge 28 55 Cash flow hedges 1 Currency translation differences 146 54 Share of other comprehensive income of associates and joint ventures 3 Effect of the reclassification of foreign exchange differences on previously held net investments in foreign entities 2 2 Total items that may be reclassified subsequently to profit and loss 117 2 Deferred tax effect Total items that may be reclassified subsequently to the income statement, net 117 2 Other comprehensive income / loss for the period, net of tax 137 80 Total comprehensive income for the period 219 382 Attributable to: Shareholders of Clariant Ltd 210 358 Non-controlling interests 9 24 Total comprehensive income for the period 219 382

Page 9 of 16 Consolidated statement of changes in equity Other reserves CHF m Total share capital Treasury shares (par value) Share premium reserves Hedging reserves Cumulative translation reserves Total other reserves Retained earnings Total attributable to equity holders Noncontrolling interests Total equity Balance 31 December 2016 1 228 29 1 319 5 1 095 229 1 033 2 461 85 2 546 Net income 277 277 25 302 Net investment hedge 55 55 55 55 Remeasurements: Actuarial gain/loss on retirement benefit obligations 7 7 7 Return on retirement benefit plan assets, 111 111 111 excluding amount included in interest expense Deferred tax on remeasurements 36 36 36 Currency translation differences 55 55 55 1 54 Share of other comprehensive income of 3 3 3 associates and joint ventures Effect of the reclassification of foreign 2 2 2 2 exchange differences on previously held net investments in foreign entities Total comprehensive income for the period 2 2 356 358 24 382 Distributions 148 148 148 148 Dividends to non-controlling interests 29 29 Transaction with non-controlling interests 99 99 Employee share & option scheme: Effect of employee services 2 2 2 Treasury share transactions 19 72 91 91 Balance 31 December 2017 1 228 10 1 171 5 1 093 83 1459 2 760 179 2 939 Changes in accounting policy 1 4 4 4 Balance 1 January 2018 1 228 10 1 171 5 1 093 83 1 455 2 756 179 2 935 Net income 337 337 19 356 Cash flow hedge 1 1 1 1 Net investment hedge 28 28 28 28 Remeasurements: Actuarial gain/ loss retirement benefit obligations 126 126 126 Return on retirement benefit plan assets, 149 149 149 excluding amount included in interest expense Deferred tax on remeasurements 1 1 1 Currency translation differences 136 136 136 10 146 Fair value adjustment on financial assets 2 2 2 Effect of the reclassification of foreign 2 2 2 2 exchange differences on previously held net investments in foreign entities Total comprehensive income for the period 1 106 107 317 210 9 219 Distributions 165 165 165 165 Dividends to non-controlling interests 16 16 Employee share & option scheme: Effect of employee services 12 12 12 Treasury share transactions 2 7 9 9 Balance 31 December 2018 1 228 8 1 006 4 1 199 189 1 767 2 798 172 2 970 1 The impact of change in accounting policy includes CHF 4 million related to IFRS 9 implementation. See Note 2

Page 10 of 16 Consolidated statements of cash flows CHF m 2 018 2 017 Net income 356 302 Adjustment for: Depreciation and amortization 325 301 Impairment and reversal of impairment 16 Impairment of working capital 23 4 Income from associates and joint ventures 130 103 Tax expense 109 135 Net financial income and costs 81 65 Loss/(gain) from the disposal of activities not qualifying as discontinued operations 54 3 Other non-cash items 24 37 Total reversal of non-cash items 438 452 Dividends received from associates and joint ventures 50 45 Payments for restructuring 42 40 Cash flow before changes in working capital and provisions 802 759 Changes in inventories 156 125 Changes in trade receivables 71 101 Changes in trade payables 121 38 Changes in other current assets and liabilities 39 46 Changes in provisions (excluding payments for restructuring) 52 4 Cash generated from operating activities 747 529 Income taxes paid 217 101 Net cash generated from operating activities 530 428 Investments in property, plant and equipment 237 248 Investments in intangible assets 20 31 Investments in financial assets, associates and joint ventures 4 10 Sale of property, plant and equipment and intangible assets 14 6 Changes in short-term deposits 20 237 Changes in current financial assets 5 1 Business acquisitions 58 Proceeds from the disposal of associates and financial assets 62 35 Proceeds associated to disposals of activities not qualifying as discontinued operations 38 17 Net cash provided by/used in investing activities 132 65 Sale of treasury shares 82 Distributions from the reserves to the shareholders of Clariant Ltd 165 148 Dividends paid to non-controlling interest 16 29 Proceeds from financial debts 350 78 Repayments of financial debts 354 718 Interest paid 79 109 Interest received 18 18 Net cash provided by/used in financing activities 246 826 Currency translation effect on cash and cash equivalents 20 9 Net change in cash and cash equivalents 132 342 Cash and cash equivalents at the beginning of the period 701 1043 Cash and cash equivalents at the end of the period 833 701

Page 11 of 16 NOTES TO THE CONDENSED FINANCIAL STATEMENTS (UNAUDITED) 1. Basis of preparation of financial statements These financial statements are the condensed consolidated financial statements (hereafter the consolidated financial statements ) of Clariant Ltd, a company registered in Switzerland, and its subsidiaries (hereafter the Group ) for the twelve-month period ended on 31 December 2018. The condensed consolidated financial statements, which do not contain all the information that International Financial Reporting Standards (IFRS) would require for a full set of financial statements, have been prepared in accordance with IFRS and with the accounting policies set out in the Clariant Financial Report for the year ended 2018. The accounting policies applied are consistent with the ones applied at year-end 2017, with the exception of those financial positions and elements of income and expenses regulated by IFRS 9 and IFRS 15, which became effective as of 1 January 2018. For more information on the effect of these standards see Note 2. These consolidated financial statements were approved on 11 February 2019 by the Board of Directors. The preparation of the condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, and disclosure of contingent liabilities at the date of the consolidated financial statements. If, in the future, such estimates and assumptions, which are based on management s best judgment at the date of the consolidated financial statements, deviate from the actual circumstances, the original estimates and assumptions will be modified as appropriate in the year in which the circumstances change. 2. New accounting standards The Group has applied the following standards and amendments for the first time: IFRS 9 Financial Instruments IFRS 15 Revenue from Contracts with Customers Classification and Measurement of Share-based Payment Transactions Amendments to IFRS 2 Annual improvements 2014 2016 Cycle Transfers to Investment Property Amendments to IAS 40 Interpretation 22 Foreign Currency Transactions and Advance Consideration The Group had to change its accounting policies and made certain adjustments as of 1 January 2018 following the adoption of IFRS 9 and IFRS 15. The other amendments listed above did not have any impact on the amounts recognized in prior periods and are not expected to significantly affect the current of future periods. IFRS 9, Financial Instruments, addresses the classification, measurement and derecognition of financial assets and financial liabilities and introduces new rules for hedge accounting and a new impairment model. To a large extent, the Group s financial assets are made up of trade receivables measured at amortized costs and other current assets which are measured at fair value. The rules for the determination of any need for impairment of trade receivables are such that they did not result in any material difference under IFRS 9 compared to the accounting rules under IAS 39. The Group only holds a small amount of equity investments as of 1 January 2018 and their measurement at fair value has only a moderate impact on the financial statement. Short-term deposits consist of money market funds of a duration between three and twelve months placed with banks of high quality. Fair value fluctuations of these instruments are only minimal. The Group continues to measure all financial liabilities at amortized cost; thus, no change in measurement has taken place. The Group has designed its hedging activities in a way that the change in accounting rules from IAS 39 to IFRS 9 did not result in any changes in hedge accounting. Also, the Group does not engage in additional hedge accounting as a result of the introduction of the new rules regarding hedge accounting. The impact of the new standard amounted to a total of CHF 4 million net of tax, which resulted from the measurement at fair value of some participations in other companies that were previously measured at amortized cost and that were recognized in the opening balance of 2018. IFRS 15, Revenue from contracts with customers, deals with revenue recognition and establishes principles for disclosing useful information about revenue and cash flows arising from these contracts. This standard replaces IAS 18, Revenue, and IAS 11, Construction Contracts, and related interpretations. It is effective for accounting periods beginning on or after 1 January 2018. Clariant as a manufacturer and seller of industrial goods is engaged to the largest extent in transactions that are accounted for in the same manner under IFRS 15 as under the previous standards. Administrative procedures are such that contracts with customers are readily identifiable once they are agreed upon. Performance obligations for products and services can be identified by individual product numbers, which are also invoiced individually, allowing for the determination and allocation of the transaction price. Revenues from the sale of goods are recognized at a point in time.

Page 12 of 16 Services are normally invoiced separately and commensurate with the services rendered and thus recognized over time. As an industrial company with a large number of customers placing relatively small orders at a time, the Company does not incur substantial contract-related costs. in companies engaged in activities closely related to those of Clariant. These shareholdings are valued at fair value using Level 3 methods to determine the fair value. The participations amounted to a total value of CHF 198 million at 31 December 2018 and are reported as part of financial assets. Sales of goods and services are recognized in line with the requirements of IFRS 15, Revenue from contracts with customers. Revenue is measured based on the consideration the Group expects to receive in exchange for the goods or services. Revenue from sales of goods is recognized in the income statement when control has been transferred to the buyer, which is usually upon delivery, at a fixed or determinable price, and when collectability is reasonably assured. Delivery is defined based on the terms of the sale contract. Revenue from services is recognized when the respective services have been rendered. Revenue is reported net of sales taxes, returns, discounts and rebates. Rebates to customers are provided for in the same period that the related sales are recorded based on the contract terms. As a consequence the recognition and valuation rules required by IFRS 15 did not have any material impact on the financial statements of the Group. 3. Seasonality of operations The Group operates in industries where significant seasonal or cyclical variations in total sales are not experienced during the financial year. 4. Investments in associates and joint ventures Clariant reduced the stake in Stahl LUX 2 from 19.7 % to 14.8 %. Income from associates and joint ventures includes CHF 59 million resulting from the partial disposal of the participation in Stahl and subsequent revaluation of the remaining shareholdings to the fair value. The amount was allocated to the Business Areas. 5. Fair value measurement All derivative financial instruments held by the Group at the end of 2018 are classified as Level 2 as defined by IFRS 13 Fair Value Measurement. Clariant is also the owner of a number of small-scale participations 6. Restructuring, impairment and transactionrelated costs During 2018, Clariant recorded restructuring expenses in the amount of CHF 14 million, mainly pertaining to projects in Europe as well as in the United States, and transaction-related costs in the amount of CHF 79 million totaling CHF 93 million. In the previous year, restructuring, impairment and transactionrelated costs amounted to CHF 180 million. 7. Disposals Clariant sold 100 % of its shares in Infrapark Baselland AG to GETEC heat & power GmbH for a total consideration of CHF 40 million. The loss recorded on the transaction in 2018 amounted to CHF 43 million net of tax and CHF 54 million before taxes. 8. Distribution from reserves On 19 March 2018, the Annual General Meeting approved a distribution of CHF 0.50 per registered share from capital contribution reserves. On 26 March 2018, a distribution totaling CHF 165 million was made to Clariant shareholders. 9. Repayment of financial liabilities On 26 September 2018, a bond issued in 2012 in the amount of CHF 250 million reached maturity and was repaid. 10. Launch of new certificates of indebtedness On 25 September 2018, Clariant issued four certificates of indebtedness with a total amount of EUR 265 million (CHF 299 million). These certificates have the following terms: EUR 92 million for 5.5 years at 1.194 % p.a. fixed, EUR 102 million for 7 years at 1.548 % p.a. fixed, EUR 54 million for 7 years at 0.95 % p.a. variable interest rate and EUR 17 million for 10 years at 2.087 % p.a. fixed. The variable interest rate is based on the 6- month EURIBOR plus spread.

Page 13 of 16 11. Business Area figures Sales to 3rd parties EBITDA before exceptionals EBITDA CHF m 2 018 2 017 % CHF % LC 2 018 2 017 % CHF 2 018 2 017 % CHF Care Chemicals 1665 1 575 6 7 316 290 9 314 260 21 Catalysis 861 767 12 11 199 198 1 185 192 4 Natural Resources 1394 1357 3 8 179 207 14 157 194 19 Plastics & Coatings 2703 2678 1 1 412 388 6 408 387 5 Business Areas total 6623 6377 1106 1083 1064 1033 Corporate 88 109 193 220 Total 6623 6377 4 5 1018 974 5 871 813 7 Operating income before exceptionals Operating income Systematic depreciation of PPE CHF m 2 018 2 017 % CHF 2 018 2 017 % CHF 2 018 2 017 Care Chemicals 253 230 10 251 200 26 56 54 Catalysis 125 135 7 111 128 13 55 41 Natural Resources 118 148 20 96 134 28 38 36 Plastics & Coatings 332 310 7 328 297 10 66 68 Business Areas total 828 823 786 759 215 199 Corporate 135 150 240 263 30 32 Total 693 673 3 546 496 10 245 231 12. Business Area margins Sales to 3rd parties EBITDA before EBITDA (Share of Total) exceptionals in % 2 018 2 017 2 018 2 017 2 018 2 017 Care Chemicals 25.1 24.7 19.0 18.4 18.9 16.5 Catalysis 13.1 12.0 23.1 25.8 21.5 25.0 Natural Resources 21.0 21.3 12.8 15.3 11.3 14.3 Plastics & Coatings 40.8 42.0 15.2 14.5 15.1 14.5 Total 100.0 100.0 15.4 15.3 13.2 12.7 Operating income Operating income b. exceptionals in % 2 018 2 017 2 018 2 017 Care Chemicals 15.2 14.6 15.1 12.7 Catalysis 14.5 17.6 12.9 16.7 Natural Resources 8.5 10.9 6.9 9.9 Plastics & Coatings 12.3 11.6 12.1 11.1 Total 10.5 10.6 8.2 7.8

Page 14 of 16 13. Condensed earnings per share data 2 018 2 017 Net income attributable to shareholders of Clariant Ltd (CHF m) 337 277 Shares Number of registered shares at 31.12.2018 and 31.12.2017 respectively 331 939 199 331 939 199 Weighted average number of shares outstanding 329 613 975 328 310 895 Adjustment for granted Clariant shares 833033 1704035 Adjustment for dilutive share options Weighted average diluted number of shares outstanding 330 447 008 330 014 930 Basic earnings per share attributable to shareholders of Clariant Ltd (CHF/share) 1.02 0.84 Diluted earnings per share attributable to shareholders of Clariant Ltd (CHF/share) 1.02 0.84 14. Finance income and costs Finance income in CHF m 2018 2017 Interest income 12 12 Other financial income 7 23 Total finance income 19 35 Finance costs in CHF m 2018 2017 Interest costs 88 93 thereof effect of discounting of non-current provisions 3 5 thereof interest component of pension provisions 15 17 Other financial expenses 12 7 Total finance costs before currency result 100 100 Currency result, net 6 Total finance costs 100 94

Page 15 of 16 15. Foreign exchange rates Rates used to translate the consolidated balance sheets (closing rates) 31.12.2018 31.12.2017 Change % 1 USD 0.98 0.98 1 EUR 1.13 1.17 3 1 BRL 0.25 0.29 14 1 CNY 0.14 0.15 7 100 INR 1.41 1.53 8 100 JPY 0.90 0.87 3 Average sales-weighted rates used to translate the consolidated income 2 018 2 017 Change % statements and consolidated statements of cash flows 1 USD 0.98 0.99 1 1 EUR 1.15 1.11 4 1 BRL 0.27 0.31 13 1 CNY 0.15 0.15 100 INR 1.43 1.52 6 100 JPY 0.89 0.88 1

Page 16 of 16 CLARIANT WHAT IS PRECIOUS TO YOU? Clariant is a focused and innovative specialty chemical company, based in Muttenz near Basel/Switzerland. On 31 December 2018 the company employed a total workforce of 17 901. In the financial year 2018, Clariant recorded sales of CHF 6.623 billion for its continuing businesses. Clariant s corporate strategy is based on five pillars: focus on innovation and R&D, add value with sustainability, reposition portfolio, intensify growth, and increase profitability. The company reports in four Business Areas: Care Chemicals, Catalysis, Natural Resources, and Plastics & Coatings. www.clariant.com Calendar of Corporate Events Your Clariant Contacts 01 April 2019 Annual General Meeting 30 April 2019 First Quarter 2019 Reporting 25 July 2019 First Half 2019 Reporting 30 October 2019 Nine Months 2019 Reporting Investor Relations Fax +41 61 469 67 67 Anja Pomrehn Tel. +41 61 469 63 73 Maria Ivek Tel. +41 61 469 63 73 Media Relations Fax +41 61 469 69 99 Jochen Dubiel Tel. +41 61 469 63 63 Thijs Bouwens Tel. +41 61 469 63 63 Disclaimer This document contains certain statements that are neither reported financial results nor other historical information. This document also includes forward-looking statements. Because these forward-looking statements are subject to risks and uncertainties, actual future results may differ materially from those expressed in or implied by the statements. Many of these risks and uncertainties relate to factors that are beyond Clariant s ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behavior of other market participants, the actions of governmental regulators and other risk factors such as: the timing and strength of new product offerings; pricing strategies of competitors; the Company s ability to continue to receive adequate products from its vendors on acceptable terms, or at all, and to continue to obtain sufficient financing to meet its liquidity needs; and changes in the political, social, and regulatory framework in which the Company operates or in economic or technological trends or conditions, including currency fluctuations, inflation, and consumer confidence, on a global, regional, or national basis. Readers are cautioned not to place undue reliance on these forwardlooking statements, which speak only as of the date of this document. Clariant does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date of these materials.